External Pacemaker Market
External Pacemaker Market Forecasts to 2030 - Global Analysis By Device (Single Chamber and Dual Chamber), By Application (Acute Myocardial Infarction, Bradycardia, Heart Block and Other Applications), End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $1.76 BN |
|
Projected Year Value (2030) |
US $2.54 BN |
|
CAGR (2023-2030) |
5.4% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global External Pacemaker Market is accounted for $1.76 billion in 2023 and is expected to reach $2.54 billion by 2030 growing at a CAGR of 5.4% during the forecast period. An external pacemaker is a medical device designed to regulate heart rhythm by delivering electrical impulses externally. It consists of electrodes connected to an external generator that emits controlled electrical signals. This device is placed on the patient's chest and transmits electrical pulses to the heart, addressing abnormal heart rhythms like bradycardia or other conduction abnormalities until a permanent solution is implemented.
According to the Centers for Disease Control and Prevention (CDC), approximately every 40 seconds an American will have a heart attack. Every year, 805,000 Americans have a heart attack, 605,000 of them for the first time.
Market Dynamics:
Driver:
Growing geriatric population
Elderly individuals commonly experience heart rhythm abnormalities like bradycardia or heart block. As the ageing demographic expands, there's a higher prevalence of cardiac conditions necessitating pacemaker intervention. External pacemakers serve as temporary solutions in these cases, providing immediate cardiac support while patients await permanent implantation or temporary measure post-cardiac procedures. Additionally, the rising ageing population worldwide directly correlates with an increased demand for external pacemakers, fostering market growth.
Restraint:
High cost of pacemakers
These devices are crucial for cardiac management, but they involve substantial expenses for both procurement and maintenance. The sophisticated technology, materials, and manufacturing processes contribute to elevated prices. Additionally, healthcare budget constraints and limited insurance coverage in certain regions create financial barriers, hindering patient access to these life-saving devices, which limits their accessibility to a broader population.
Opportunity:
Increasing disposable income in emerging economies
Due to the rise in income levels, emerging economies can afford advanced healthcare services and devices, including pacemakers. This leads to a higher demand for cardiac care and better access to expensive medical technologies. Improved affordability allows a larger segment of the population to opt for pacemaker implantations or treatments, boosting market growth. Moreover, increased healthcare spending and better insurance coverage contribute to expanded adoption rates, creating a favourable market landscape in these economies.
Threat:
Competition from alternative therapies
Alternative treatments like medication, lifestyle changes, or other non-invasive cardiac interventions present alternatives to pacemaker implantation. For certain cardiac conditions, patients might opt for alternative therapies before considering a pacemaker due to concerns about surgery, device dependency, or cost. Moreover, advancements in non-invasive procedures and research into alternative treatments offer viable options, potentially reducing the immediate need for pacemakers.
Covid-19 Impact:
The COVID-19 pandemic had a substantial impact on the external pacemaker market. Disruptions in healthcare services, elective procedures, and hospital visits led to deferred non-emergency treatments, including pacemaker implantations. Supply chain disruptions and the prioritisation of resources for pandemic-related care affected device availability. Patient reluctance to seek medical care and hospitalisations also contributed to reduced pacemaker procedures, resulting in a temporary decline in market growth.
The hospitals segment is expected to be the largest during the forecast period
During the forecast period, the hospitals segment is poised to dominate. Hospitals serve as primary centres for cardiac care, equipped with specialised infrastructure and skilled healthcare professionals capable of diagnosing and treating complex cardiac conditions requiring external pacemakers. Additionally, these facilities often witness a high influx of patients requiring immediate cardiac interventions, making them primary hubs for pacemaker implantations and management. The comprehensive healthcare services and specialised cardiology departments in hospitals solidify their position as the largest contributors to the external pacemaker market.
The heart block segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the heart block segment is anticipated to experience a lucrative growth rate. This is attributed to the increasing prevalence of heart block conditions, where the heart's electrical signals are delayed or obstructed. External pacemakers serve as essential temporary solutions for regulating the heart's rhythm in such cases, contributing to their heightened demand. Additionally, advancements in technology and a growing awareness of cardiac health are expected to drive the adoption of external pacemakers for heart block management, fueling the segment's rapid growth.
Region with largest share:
North America is positioned to secure the largest market share in the external pacemaker market owing to its advanced healthcare infrastructure, high prevalence of cardiac disorders, and substantial healthcare expenditure. Additionally, the presence of key market players and extensive research and development activities contribute to market dominance. Furthermore, increasing initiatives for technological advancements in cardiac care and a proactive approach to adopting innovative medical solutions reinforce North America's prominence in the external pacemaker market.
Region with highest CAGR:
The Asia-Pacific region is poised for significant growth in the external pacemaker market due to the region's rising prevalence of cardiac disorders and an expanding geriatric population. Additionally, improving healthcare infrastructure, growing awareness about advanced medical treatments, and rising disposable incomes contribute to higher adoption rates of external pacemakers. Moreover, collaborations with international medical device manufacturers and supportive government initiatives further drive market expansion, indicating substantial growth prospects for the Asia-Pacific External Pacemaker market.
Key players in the market
Some of the key players in External Pacemaker Market include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Cardiac Science Corporation, Cook Medical, Galix Biomedical Instrumentation, LivaNova Plc, Medtronic, Osypka Medical GmbH, Reka Health Pte Ltd., Schiller AG, Shree Pacetronix Ltd., Spacelabs Healthcare and ZOLL Medical Corporation.
Key Developments:
In December 2023, Medtronic plc, a global leader in healthcare technology, announces that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals. This AI-driven partnership will further capitalize on the achievements already realized with the GI Genius™ intelligent endoscopy module, offering continued innovation and scalable healthcare advancements for patients and caregivers globally.
In November 2023, Boston Scientific Corporation announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept® Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain that is a form of chronic low back pain. The Intracept system, a basivertebral nerve ablation therapy, will be an addition to the Boston Scientific chronic pain portfolio that includes spinal cord stimulation, radiofrequency ablation and an interspinous spacer procedure.
In July 2023, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms. With more than 80% of people who need a pacemaker requiring pacing in two chambers of the heart (both the right atrium and right ventricle), the approval significantly increases access to leadless pacing for millions of people across the U.S.
Devices Covered:
• Single Chamber
• Dual Chamber
Applications Covered:
• Acute Myocardial Infarction
• Bradycardia
• Heart Block
• Post-Operative Care
• Tachycardia
• Other Applications
End Users Covered:
• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Home Healthcare
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global External Pacemaker Market, By Device
5.1 Introduction
5.2 Single Chamber
5.3 Dual Chamber
6 Global External Pacemaker Market, By Application
6.1 Introduction
6.2 Acute Myocardial Infarction
6.3 Bradycardia
6.4 Heart Block
6.5 Post-Operative Care
6.6 Tachycardia
6.7 Other Applications
7 Global External Pacemaker Market, By End User
7.1 Introduction
7.2 Hospitals
7.3 Ambulatory Surgical Centers
7.4 Clinics
7.5 Home Healthcare
7.6 Other End Users
8 Global External Pacemaker Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Abbott Laboratories
10.2 Biotronik
10.3 Boston Scientific Corporation
10.4 Cardiac Science Corporation
10.5 Cook Medical
10.6 Galix Biomedical Instrumentation
10.7 LivaNova Plc
10.8 Medtronic
10.9 Osypka Medical GmbH
10.10 Reka Health Pte Ltd.
10.11 Schiller AG
10.12 Shree Pacetronix Ltd.
10.13 Spacelabs Healthcare
10.14 ZOLL Medical Corporation
List of Tables
1 Global External Pacemaker Market Outlook, By Region (2021-2030) ($MN)
2 Global External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
3 Global External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
4 Global External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
5 Global External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
6 Global External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
7 Global External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
8 Global External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
9 Global External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
10 Global External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
11 Global External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
12 Global External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
13 Global External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
14 Global External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
15 Global External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
16 Global External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
17 Global External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
18 North America External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
19 North America External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
20 North America External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
21 North America External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
22 North America External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
23 North America External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
24 North America External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
25 North America External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
26 North America External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
27 North America External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
28 North America External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
29 North America External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
30 North America External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
31 North America External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
32 North America External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
33 North America External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
34 North America External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
35 Europe External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
36 Europe External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
37 Europe External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
38 Europe External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
39 Europe External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
40 Europe External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
41 Europe External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
42 Europe External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
43 Europe External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
44 Europe External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
45 Europe External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
46 Europe External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
47 Europe External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
48 Europe External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
49 Europe External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
50 Europe External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
51 Europe External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
52 Asia Pacific External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
53 Asia Pacific External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
54 Asia Pacific External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
55 Asia Pacific External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
56 Asia Pacific External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
57 Asia Pacific External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
58 Asia Pacific External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
59 Asia Pacific External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
60 Asia Pacific External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
61 Asia Pacific External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
62 Asia Pacific External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
63 Asia Pacific External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
64 Asia Pacific External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
65 Asia Pacific External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
66 Asia Pacific External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
67 Asia Pacific External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
68 Asia Pacific External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
69 South America External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
70 South America External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
71 South America External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
72 South America External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
73 South America External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
74 South America External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
75 South America External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
76 South America External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
77 South America External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
78 South America External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
79 South America External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
80 South America External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
81 South America External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
82 South America External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
83 South America External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
84 South America External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
85 South America External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
86 Middle East & Africa External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
87 Middle East & Africa External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
88 Middle East & Africa External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
89 Middle East & Africa External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
90 Middle East & Africa External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
91 Middle East & Africa External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
92 Middle East & Africa External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
93 Middle East & Africa External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
94 Middle East & Africa External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
95 Middle East & Africa External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
96 Middle East & Africa External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
97 Middle East & Africa External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
98 Middle East & Africa External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
99 Middle East & Africa External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
100 Middle East & Africa External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
101 Middle East & Africa External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
102 Middle East & Africa External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
